Back to search

Switzerland· 67074002

Ezetimib-Simvastatin-Mepha Teva 10/20 mg, Tabletten

A simvastatin and ezetimibe product, registered in Switzerland by Mepha Pharma AG and dispensed under Swissmedic category B. The same ATC class is registered in 13 of our 19 countries.

Cat B (Swissmedic)ATC C10BA02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedEzetimib-Simvastatin-Mepha Teva 10/20…ATCC10BA02REGISTER NO.67074002PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Simvastatin and ezetimibe is registered in 13 of 19 countries.

Countries holding a registration under ATC C10BA02 (simvastatin and ezetimibe), each read from that country’s own register.

  • This record: Switzerland
  • 9 of them publish a price we can compare per daily dose

Simvastatin and ezetimibe · ATC C10BA02

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Mepha Pharma AG
Country
Switzerland (CH)
ATC code
C10BA02
ATC class
Simvastatin and ezetimibe
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

14 interactions on record for simvastatin and ezetimibe.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Simvastatin and ezetimibe · interactions on record

14 records

14 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be8327a4-fd65-4edc-ae2a-2052e980f7b8
GET /v1/drugs/be8327a4-fd65-4edc-ae2a-2052e980f7b8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about simvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.